LOWY 2015* Mark Devlin
Cancer Therapeutics CRC, VIC, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Discovery of CTx-0391034 a novel potent and selective inhibitor of PRMT5 (#151)
2:15 PM
Brendon Monahan
Afternoon Tea/Poster Session